URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Shreedevi Pandya

Concepts (249)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of pubs Most recent pub Pubs by all authors Concept score Why?
Muscular Dystrophy, Duchenne
13
2001
50
3.030
Why?
Muscular Dystrophies
23
1981
183
1.600
Why?
Prednisone
12
1981
178
1.530
Why?
Dermatomyositis
1
2011
29
0.760
Why?
Glucocorticoids
2
2009
159
0.720
Why?
Myotonia
3
2007
42
0.710
Why?
Genetic Vectors
3
1999
328
0.710
Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2011
89
0.710
Why?
Receptors, Tumor Necrosis Factor
1
2011
130
0.700
Why?
Severity of Illness Index
6
1996
878
0.680
Why?
Muscular Dystrophy, Facioscapulohumeral
2
2001
24
0.680
Why?
Immunoglobulin G
1
2011
491
0.640
Why?
Quality of Life
5
2009
486
0.630
Why?
Adolescent
30
1981
4513
0.610
Why?
Genetic Predisposition to Disease
1
2008
306
0.540
Why?
Child
27
1983
3897
0.530
Why?
Humans
57
1981
35000
0.510
Why?
Male
44
1981
18870
0.500
Why?
Myositis, Inclusion Body
2
2008
25
0.500
Why?
Young Adult
7
2008
1013
0.460
Why?
Adult
29
1984
10906
0.460
Why?
Simian immunodeficiency virus
2
1999
30
0.460
Why?
Mutation
2
2008
1183
0.460
Why?
Lentivirus
2
1999
26
0.450
Why?
Myotonic Dystrophy
4
1989
209
0.420
Why?
Amphotericin B
1
2002
25
0.410
Why?
Mycoses
1
2002
30
0.400
Why?
Population Surveillance
4
2006
120
0.400
Why?
Child, Preschool
22
1983
2452
0.390
Why?
Voice
1
2011
4
0.390
Why?
Antifungal Agents
1
2002
61
0.390
Why?
Telephone
1
2011
22
0.380
Why?
Gene Products, rev
1
2001
4
0.380
Why?
Middle Aged
19
1989
9461
0.380
Why?
Spumavirus
1
2001
1
0.370
Why?
Hand Strength
3
2001
33
0.370
Why?
Medical Records
1
2011
122
0.370
Why?
HIV-1
3
1999
544
0.370
Why?
Treatment Outcome
8
1997
2487
0.360
Why?
Gene Deletion
3
1996
191
0.360
Why?
Dose-Response Relationship, Drug
4
1991
1085
0.340
Why?
Double-Blind Method
14
1984
985
0.340
Why?
Muscle Strength
2
2007
25
0.330
Why?
Female
24
1991
19061
0.320
Why?
Membrane Glycoproteins
1
2001
350
0.300
Why?
Pregnenediones
2
2005
7
0.300
Why?
Genotype
3
1996
455
0.300
Why?
Affect
2
2010
73
0.290
Why?
Muscles
13
1981
332
0.290
Why?
Pilot Projects
5
1997
426
0.260
Why?
Drug Administration Schedule
4
1991
362
0.260
Why?
Muscle Weakness
2
2007
39
0.240
Why?
Isometric Contraction
3
1994
47
0.240
Why?
Physical Therapy Modalities
3
1985
27
0.240
Why?
Muscle, Skeletal
3
2006
409
0.230
Why?
Shoulder
3
1994
23
0.230
Why?
Caregivers
2
2011
71
0.220
Why?
Muscular Diseases
2
1981
67
0.220
Why?
Cohort Studies
4
2008
912
0.220
Why?
Face
2
1997
46
0.200
Why?
Exercise Test
1
2012
88
0.200
Why?
Perception
1
2012
60
0.200
Why?
Genetic Testing
2
2008
92
0.200
Why?
Infant
6
1983
2102
0.200
Why?
Neuromuscular Diseases
1
2011
50
0.190
Why?
Complementary Therapies
1
2011
37
0.190
Why?
Health Status Indicators
1
2011
97
0.190
Why?
Neurologic Examination
1
2011
143
0.190
Why?
DNA Mutational Analysis
2
2006
185
0.190
Why?
Treatment Failure
1
2011
125
0.190
Why?
Muscle Contraction
3
1983
169
0.180
Why?
Kaplan-Meier Estimate
1
2011
190
0.180
Why?
Psychometrics
1
2011
212
0.180
Why?
Insulin-Like Growth Factor Binding Protein 3
1
2010
14
0.180
Why?
Point Mutation
2
1996
169
0.180
Why?
Aged
8
1989
6986
0.180
Why?
Biopsy
2
2006
359
0.180
Why?
Healthcare Disparities
1
2011
72
0.180
Why?
Anti-Inflammatory Agents
1
2011
109
0.180
Why?
Albuterol
2
1998
26
0.170
Why?
Adrenergic beta-Agonists
2
1998
52
0.170
Why?
Insulin-Like Growth Factor I
1
2010
98
0.170
Why?
Adrenal Cortex Hormones
1
2010
98
0.170
Why?
Spinal Muscular Atrophies of Childhood
1
2009
12
0.170
Why?
Palliative Care
1
2011
151
0.170
Why?
Gene Duplication
1
2008
9
0.160
Why?
Dystrophin
1
2008
12
0.160
Why?
Gene Frequency
1
2008
83
0.160
Why?
Genetic Markers
1
2008
127
0.160
Why?
Health Knowledge, Attitudes, Practice
1
2011
247
0.150
Why?
Drug Eruptions
1
2008
28
0.150
Why?
Patient Care Team
1
2009
189
0.150
Why?
Recombinant Proteins
1
2010
706
0.150
Why?
Clinical Protocols
2
1994
102
0.150
Why?
Joints
2
1981
56
0.150
Why?
Software
2
1987
126
0.140
Why?
Disability Evaluation
1
2008
125
0.140
Why?
Antibodies
1
2008
207
0.140
Why?
Nifedipine
1
1987
33
0.140
Why?
Muscular Dystrophies, Limb-Girdle
1
2006
4
0.140
Why?
Extremities
1
1997
33
0.140
Why?
Abstracting and Indexing as Topic
1
2006
8
0.140
Why?
Time Factors
10
1984
3047
0.140
Why?
Electrodiagnosis
1
2007
49
0.140
Why?
Genes, Dominant
1
1997
78
0.140
Why?
Risk Assessment
2
2005
808
0.140
Why?
Longitudinal Studies
2
2011
372
0.130
Why?
Data Collection
1
2006
201
0.130
Why?
Action Potentials
1
2007
248
0.130
Why?
Creatine Kinase
3
1981
51
0.110
Why?
Clinical Trials as Topic
9
1981
664
0.110
Why?
Questionnaires
3
2011
942
0.100
Why?
Arm
2
1997
52
0.100
Why?
Single-Blind Method
1
2002
114
0.100
Why?
Weight Gain
4
1991
53
0.100
Why?
rev Gene Products, Human Immunodeficiency Virus
1
2001
3
0.100
Why?
Oxandrolone
1
2001
4
0.100
Why?
HIV Long Terminal Repeat
1
2001
8
0.100
Why?
Anabolic Agents
1
2001
14
0.100
Why?
DNA, Recombinant
1
2001
40
0.100
Why?
Follow-Up Studies
5
1985
1757
0.090
Why?
Virus Assembly
1
2001
17
0.090
Why?
Genes, Viral
1
2001
88
0.090
Why?
Response Elements
1
2001
75
0.090
Why?
Transgenes
1
2001
69
0.090
Why?
Viral Envelope Proteins
1
2001
90
0.090
Why?
Reproducibility of Results
4
1992
859
0.090
Why?
Models, Genetic
1
2001
157
0.090
Why?
Cloning, Molecular
1
2001
495
0.090
Why?
Muscle Fatigue
1
1999
11
0.080
Why?
Iowa
2
2006
7
0.080
Why?
Colorado
2
2006
14
0.080
Why?
Arizona
2
2006
21
0.080
Why?
DNA, Viral
1
2001
288
0.080
Why?
Viral Proteins
1
2001
216
0.080
Why?
Cell Division
1
2001
735
0.080
Why?
Contracture
4
1983
25
0.080
Why?
Activities of Daily Living
2
2008
250
0.080
Why?
Multiple Sclerosis
1
1999
125
0.080
Why?
Randomized Controlled Trials as Topic
1
2010
400
0.070
Why?
United States
3
2006
2511
0.070
Why?
Infant, Newborn
1
2002
1772
0.070
Why?
Transcription, Genetic
1
2001
795
0.070
Why?
Cell Line
1
2001
1554
0.070
Why?
Disease Progression
2
1997
496
0.070
Why?
Diagnosis, Differential
2
2007
855
0.060
Why?
Random Allocation
4
1987
245
0.060
Why?
New York
2
2006
1191
0.060
Why?
Computers
2
1981
81
0.060
Why?
Respiratory Function Tests
3
1987
121
0.060
Why?
Prospective Studies
3
1987
1606
0.060
Why?
Retrospective Studies
2
2009
2167
0.060
Why?
Evaluation Studies as Topic
2
1984
240
0.050
Why?
Azathioprine
1
1993
20
0.050
Why?
Electromyography
3
1987
170
0.050
Why?
Chloride Channels
1
2012
69
0.050
Why?
Diagnosis, Computer-Assisted
1
2012
64
0.050
Why?
Georgia
1
2011
14
0.050
Why?
Sodium Channels
1
2012
117
0.050
Why?
Qualitative Research
1
2011
54
0.050
Why?
Interview, Psychological
1
2011
70
0.050
Why?
Great Britain
1
2011
95
0.050
Why?
Employment
1
2011
62
0.050
Why?
Family Health
1
2011
84
0.050
Why?
Hispanic Americans
1
2011
86
0.050
Why?
Linear Models
1
2011
228
0.050
Why?
Injections, Subcutaneous
1
2010
89
0.050
Why?
Drug Combinations
1
2010
142
0.040
Why?
Attitude to Health
1
2012
198
0.040
Why?
Aged, 80 and over
2
2006
2423
0.040
Why?
Physical Therapy Specialty
1
2009
1
0.040
Why?
Language Disorders
1
2009
14
0.040
Why?
Respiration Disorders
1
2009
6
0.040
Why?
Nutritional Requirements
1
2009
16
0.040
Why?
Gastrointestinal Diseases
1
2009
38
0.040
Why?
European Continental Ancestry Group
1
2011
225
0.040
Why?
Bone Diseases
1
2009
37
0.040
Why?
Exercise Therapy
1
2009
33
0.040
Why?
Pain Management
1
2009
46
0.040
Why?
African Americans
1
2011
209
0.040
Why?
Early Diagnosis
1
2009
29
0.040
Why?
Penicillamine
1
1988
26
0.040
Why?
Age of Onset
1
2009
120
0.040
Why?
Heart Diseases
1
2009
132
0.040
Why?
Ambulatory Care
1
2009
140
0.040
Why?
Internationality
1
2008
22
0.040
Why?
Placebo Effect
1
2008
36
0.040
Why?
Vitamin E
1
1988
87
0.040
Why?
Testosterone
1
1989
151
0.040
Why?
Motor Activity
1
2009
179
0.040
Why?
Muscle Relaxation
1
2007
20
0.040
Why?
Placebos
2
1993
177
0.040
Why?
Trinucleotide Repeats
1
2007
41
0.040
Why?
Evidence-Based Medicine
1
2009
197
0.040
Why?
Creatinine
2
1981
128
0.040
Why?
Animals
2
1999
15647
0.040
Why?
Needles
1
2007
46
0.040
Why?
Dystroglycans
1
2006
4
0.030
Why?
Caveolin 1
1
2006
13
0.030
Why?
Body Composition
1
1997
67
0.030
Why?
Leg
1
2007
95
0.030
Why?
Organ Size
1
1997
189
0.030
Why?
Chromosomes, Human, Pair 4
1
1996
34
0.030
Why?
Comorbidity
1
2008
365
0.030
Why?
Immunophenotyping
1
2006
123
0.030
Why?
Pain
1
2009
363
0.030
Why?
Calpain
1
2006
41
0.030
Why?
Blotting, Southern
1
1996
103
0.030
Why?
Incidence
1
2008
644
0.030
Why?
Muscle Proteins
1
2006
131
0.030
Why?
Predictive Value of Tests
1
2007
579
0.030
Why?
Time
1
2005
44
0.030
Why?
Sensitivity and Specificity
1
2008
866
0.030
Why?
Prevalence
1
2006
530
0.030
Why?
Leucine
1
1984
108
0.030
Why?
Blotting, Western
1
2006
617
0.030
Why?
Movement
1
1985
162
0.030
Why?
Body Weight
2
1991
328
0.030
Why?
Phenotype
1
1996
727
0.030
Why?
Motor Skills
1
1983
46
0.030
Why?
Membrane Proteins
1
2006
530
0.030
Why?
Respiration
1
1983
176
0.030
Why?
Risk Factors
1
2008
2172
0.020
Why?
Muscle Tonus
1
2001
10
0.020
Why?
Quality Control
1
1981
72
0.020
Why?
Carnitine
1
1981
14
0.020
Why?
Body Mass Index
1
2001
207
0.020
Why?
Statistics, Nonparametric
1
2001
251
0.020
Why?
Drug Therapy, Combination
2
1988
375
0.020
Why?
Models, Biological
1
1994
982
0.020
Why?
Absorptiometry, Photon
1
1998
28
0.020
Why?
Age Factors
1
1981
1060
0.020
Why?
Research Design
2
1987
326
0.020
Why?
Biomechanics
1
1994
171
0.010
Why?
Body Height
1
1993
49
0.010
Why?
Pain Measurement
1
1994
241
0.010
Why?
Observer Variation
1
1992
137
0.010
Why?
Wheelchairs
1
1989
5
0.010
Why?
Locomotion
1
1989
26
0.010
Why?
Acne Vulgaris
1
1989
16
0.010
Why?
Cardiomyopathies
1
1989
75
0.010
Why?
Analysis of Variance
1
1991
705
0.010
Why?
Scoliosis
1
1989
49
0.010
Why?
Mice
1
1999
5900
0.010
Why?
Drug Evaluation
1
1987
98
0.010
Why?
Cost-Benefit Analysis
1
1987
200
0.010
Why?
Enzymes
1
1984
28
0.010
Why?
Methods
1
1984
210
0.010
Why?
Methylhistidines
1
1981
12
0.010
Why?

Visualizations


Pandya's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department